NEW YORK: Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they head back to school in the fall.
Most COVID-19 vaccines being rolled out worldwide are for adults, who are at higher risk from the coronavirus. Pfizer’s vaccine is authorized for ages 16 and older. But vaccinating children of all ages will be critical to stopping the pandemic — and helping schools, at least the upper grades, start to look a little more normal after months of disruption.
In the vaccine study of 2,260 U.S. volunteers ages 12 to 15, preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents compared to 18 among those given dummy shots, Pfizer reported.
It’s a small study, that hasn’t yet been published, so another important piece of evidence is how well the shots revved up the kids’ immune systems. Researchers reported high levels of virus-fighting antibodies, somewhat higher than were seen in studies of young adults.
Kids had side effects similar to young adults, the company said. The main side effects are pain, fever, chills and fatigue, particularly after the second dose. The study will continue to track participants for two years for more information about long-term protection and safety.
Dr. Philip J. Landrigan of Boston College said the results are encouraging.
“It’s hard to get kids to comply with masking and distancing, so something that gives them hard protection and takes them out of the mix of spreading the virus is all for the good,” said Landrigan, who was not involved in the study.
It’s another positive development in the race against the virus even as U.S. cases, at 66,000 new infections a day, are rising again and deaths are averaging nearly 1,000 a day. Centers for Disease Control and Prevention director Dr. Rochelle Walensky warned Americans again Wednesday that “we can’t afford to let our guard down.”
Pfizer and its German partner BioNTech in the coming weeks plan to ask the U.S. Food and Drug Administration and European regulators to allow emergency use of the shots starting at age 12.
“We share the urgency to expand the use of our vaccine,” Pfizer CEO Albert Bourla said in a statement. He expressed “the hope of starting to vaccinate this age group before the start of the next school year” in the United States.
Pfizer isn’t the only company seeking to lower the age limit for its vaccine. Results also are expected by the middle of this year from a U.S. study of Moderna’s vaccine in 12- to 17-year-olds.
But in a sign that the findings were promising, the FDA already allowed both companies to begin U.S. studies in children 11 and younger, working their way to as young as 6-month-old.
“We are longing for a normal life. This is especially true for our children,” BioNTech CEO Ugur Sahin said in a statement.
AstraZeneca last month began a study of its vaccine among 6- to 17-year-olds in Britain. Johnson & Johnson is planning its own pediatric studies. And in China, Sinovac recently announced it has submitted preliminary data to Chinese regulators showing its vaccine is safe in children as young as 3.
While most COVID-19 vaccines being used globally were first tested in tens of thousands of adults, pediatric studies won’t need to be nearly as large. Scientists have safety information from those studies and from subsequent vaccinations in millions more adults.
One key question is the dosage: Pfizer gave the 12-and-older participants the same dose adults receive, while testing different doses in younger children.
It’s not clear how quickly the FDA would act on Pfizer’s request to allow vaccination starting at age 12. The agency has taken about three weeks to review and authorize each of the vaccines currently available for adults. That process included holding a public meeting of outside experts to review and vote on the safety and effectiveness of each shot.
The process for reviewing data in children could be shorter, given FDA’s familiarity with each vaccine. An agency spokeswoman said the FDA had no information to share on how the review would work, including whether additional public meetings would be required.
Another question is when the country would have enough supply of shots — and people to get them into adolescents’ arms — to let kids start getting in line.
Supplies are set to steadily increase over the spring and summer, at the same time states are opening vaccinations to younger, healthier adults who until now haven’t had a turn.
Children represent about 13% of COVID-19 cases documented in the U.S. And while children are far less likely than adults to get seriously ill, at least 268 have died from COVID-19 in the U.S. alone and more than 13,500 have been hospitalized, according to a tally by the American Academy of Pediatrics. That’s more than die from the flu in an average year. Additionally, a small number have developed a serious inflammatory condition linked to the coronavirus.
Caleb Chung, who turns 13 later this week, agreed to volunteer after his father, a Duke University pediatrician, presented the option. He doesn’t know if he received the vaccine or a placebo.
“Usually I’m just at home doing online school and there’s not much I can really do to fight back against the virus,” Caleb said in a recent interview. The study “was really somewhere that I could actually help out.”
His father, Dr. Richard Chung, said he’s proud of his son and all the other children volunteering for the needle pricks, blood tests and other tasks a study entails.
“We need kids to do these trials so that kids can get protected. Adults can’t do that for them,” Chung said.
AP Newsroom
Thu Apr 01 2021
Pfizer's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS pic
Jemputan peribadi ke Mesyuarat Khas WEF bukti keakraban Putera Mahkota Mohammed, PM
Ini merupakan lawatan keempat Anwar ke Arab Saudi sejak dilantik sebagai Perdana Menteri.
Kerajaan Pusat peruntuk RM1.59 bilion untuk pembangunan fizikal di Terengganu
Peruntukan tersebut melibatkan 99 projek baharu dan 296 projek sambungan di bawah Rolling Plan 4 (RP4) Rancangan Malaysia ke-12 (RMK12).
Pahang rancang wujudkan zon perindustrian di setiap daerah
Kerajaan Pahang rancang wujudkan zon perindustrian di kesemua 11 daerah di negeri ini bagi menggalakkan kemasukan lebih banyak pelaburan asing khususnya dari China.
Kertas kabinet wujud sektor sukan dibentang dalam tempoh sebulan - Hannah
Hannah berkata dengan data yang lebih menyeluruh melibatkan sektor industri sukan nanti, pihaknya akan mampu merangsang pertumbuhan sukan di negara ini dengan lebih baik.
Tiga Syarikat Semikonduktor umum melabur di Pulau Pinang - Kon Yeow
Tiga syarikat semikonduktor dari China menyatakan komitmen untuk membuat pelaburan baharu di Pulau Pinang.
Pindaan garis panduan lawatan: Sekolah diharap susun semula program - Fadhlina
Semua sekolah diharap dapat menyusun semula program lawatan masing-masing berikutan pindaan Garis Panduan Lawatan Murid Sekolah pada tahun lepas bagi mengukuhkan pembelajaran di luar kelas, kata Menteri Pendidikan, Fadhlina Sidek.
Kebajikan pendidikan anak-anak dijaga sehingga tamat sekolah - KPM
Kementerian Pendidikan Malaysia akan memastikan kebajikan pendidikan anak-anak 10 pegawai dan anggota Tentera Laut Diraja Malaysia yang terkorban dalam nahas helikopter di Lumut, Perak, terus dijaga sehingga mereka tamat persekolahan.
Chegubard ditahan polis berkaitan hantaran mengenai kasino di Forest City
Chegubard ditahan di Ibu Pejabat Polis Daerah (IPD) Dang Wangi di sini berkaitan hantaran mengenai pengoperasian kasino di Forest City pada Sabtu.
Zahid minta pihak dalam BN buka "buku baharu"
Ahmad Zahid menegaskan senario politik tanah air sudah berubah dan terdapat banyak video lama dari parti lawan yang meminta pengundi menyokong DAP.
Malaysia kongsi pengalaman dalam usaha berterusan mempertahan Palestin
Delegasi negara akan berkongsikan peranan Malaysia dalam usaha berterusan mempertahankan nasib Palestin dalam Persidangan Liga Parlimen Al-Quds kelima yang berlangsung di Istanbul, Turki pada Sabtu.
WHO perbaharui gesaan untuk lindungi hospital Gaza
Ketua Pengarah WHO Dr Tedros Ghebreyesus, memperbaharui gesaan agar memberikan perlindungan kepada semua hospital di Semenanjung Gaza.
Ketua WHO gesa perlindungan kemudahan penjagaan kesihatan semasa konflik
Ghebreyesus berkata kerosakan kemudahan penjagaan kesihatan dan kakitangan WHO telah menjadi norma, seperti yang dilihat di Gaza, Sudan dan Ethiopia.
Hospital Al-Shifa umpama cangkerang kosong dengan pusara manusia - WHO
Pertubuhan Kesihatan Sedunia (WHO) berkata kemusnahan Hospital Al-Shifa menjadikannya umpama sebuah cangkerang kosong dengan pusara manusia susulan kepungan dan serangan Israel.
Malaysia laksana program pendidikan kesihatan menyeluruh, pupuk amalan berlandaskan pencegahan
Malaysia melaksanakan program pendidikan kesihatan yang menyeluruh untuk memupuk amalan penjagaan kesihatan berlandaskan pencegahan serta kesedaran kepentingan mendapatkan rawatan perubatan awal.
9,000 pesakit memerlukan pemindahan kecemasan dari Gaza
Hanya 10 hospital yang berfungsi secara minimum di seluruh Gaza dan beribu-ribu pesakit gagal mendapat penjagaan kesihatan.
Kebuluran di Gaza dijangka tidak dapat dielakkan - WHO
Pertubuhan Kesihatan Sedunia (WHO) berkata analisis terkini daripada Integrated Food Security Phase Classification (IPC) mencerminkan keadaan yang meruncing dihadapi penduduk Gaza.
Satu daripada lapan orang kini hidup dengan obesiti - WHO
Obesiti dalam kalangan orang dewasa telah meningkat lebih daripada dua kali ganda sejak 1990.
“Gaza jadi zon maut” - Ketua WHO
Situasi kesihatan dan kemanusiaan yang "tidak berperikemanusiaan" kini berlaku di seluruh Gaza dengan keadaan terus merosot.
Gaza: WHO bantu keluarkan 14 pesakit dari Hospital Nasser
WHO membantu memindahkan 14 pesakit dari Hospital Nasser di bandar Khan Younis yang dikepung tentera Israel.
Penggunaan tembakau semakin berkurangan di seluruh dunia - WHO
Pertubuhan Kesihatan Sedunia (WHO) berkata, kebanyakan negara di seluruh dunia berjaya mengurangkan penggunaan tembakau.